Roth Capital Initiates Coverage on Ambiq Micro with Buy Rating

Roth Capital has begun its coverage of Ambiq Micro, assigning a 'Buy' rating and setting a price target of $125. This initiation of coverage brings Ambiq Micro into focus for investors and analysts.